Janssen Therapeutics Announces Recipient of Its Second Point Scholarship for
TITUSVILLE, N.J., July 16, 2013
TITUSVILLE, N.J., July 16, 2013 /PRNewswire/ --Janssen Therapeutics, Division
of Janssen Products, LP (Janssen) announced today the recipient of the second
scholarship the company is supporting through the Point Foundation, the
nation's largest scholarship-granting organization for lesbian, gay, bisexual
and transgender (LGBT) students of merit. Janssen is the first pharmaceutical
company to fund a Point Scholarship.
The Point Scholarship supported by Janssen is for LGBT students whose field of
study is focused on HIV/AIDS, or who have chosen to attend business school. It
has been awarded to Michael Haymer of Orange County, California. Michael is
pursuing a joint MD-MBA degree from the PRIME Program at the David Geffen
School of Medicine at University of California, Los Angeles (UCLA).
The Point Scholarship is granted for a four-year period to graduating high
school seniors and college students. As a Point Scholar, Michael will receive
financial assistance and will be matched with a successful professional who
can serve as his mentor and role model.
Michael and his four siblings were raised by their single mother who died from
complications of undertreated diabetes during his first year of medical
school. As a tribute to her, Michael focused his studies on serving
under-resourced and vulnerable populations.
"I'm personally committed to my research and work as a community educator in
the areas of LGBT and HIV health because I know firsthand how important it is
to give a voice to underserved populations," said Michael. "With this
scholarship, I look forward to setting an example for other LGBT students
interested in healthcare and continuing the tradition of Point Scholars."
Michael has a particular interest in the area of transgender healthcare. He
directed the LGBT Health Student Symposium, which hosted more than 100
students from across the country. In recognition of his efforts, Michael
received the UCLA Diversity, Equity & Inclusion Award.
Michael also has experience in HIV research; he served as a community educator
for an international HIV vaccine trial and conducted research on the use of
mobile technology to improve community outreach methods for HIV/AIDS
In 2012, Janssen provided a Point Scholarship to medical student Siddarth
(Sid) Puri to support his studies at University of California Davis School of
Medicine. Sid was named co-director, class of 2014,of the student-run Joan
Viteri Memorial Clinic dedicated to serving the healthcare needs of uninsured
drug users. The Point Scholarship helps Sid advance his efforts to provide
culturally sensitive medical care to the LGBT community and people living with
"Since the start of the HIV epidemic, the LGBT community has played a
leadership role in mobilizing the response. While great progress has been
made, more than 30 years later HIV infection rates are rising among men who
have sex with men and communities of color," said Ron Falcon, MD, Director of
Marketing, HIV, Janssen. "Through the Point Foundation scholarship, Janssen is
investing to help develop the next generation of leaders from the LGBT
community to continue the fight against HIV."
About Janssen Therapeutics
At Janssen, we are dedicated to addressing and solving some of the most
important unmet medical needs of our time in HIV and other infectious
diseases.Driven by our commitment to patients, we develop innovative
products, services and healthcare solutions to help people throughout the
world. Headquartered in Titusville, New Jersey, Janssen Therapeutics, Division
of Janssen Products, LP, is one of the Janssen Pharmaceutical Companies.Visit
http://www.janssentherapeutics.comfor more information and follow us on
Twitter at @JanssenUS.
Pamela Van Houten
Phone: (609) 730-7902
SOURCE Janssen Therapeutics
Press spacebar to pause and continue. Press esc to stop.